We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sourcebio International Plc | SBI | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 115.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 115.00 | 115.00 |
| Top Posts |
|---|
Posted at 24/4/2024 08:54 by pldazzle Dividend cost the company c£20m in total and was evidently inspired by the sale of the Stability Storage division for - and I stress this is a pure guess on my part - perhaps £30-35m: actual proceeds have not been disclosed.In addition, the company announced in February that it was buying in just under 5m shares at 115p, so there goes another c£5.7m. Plainly the company feels well able to splash the cash without detriment to its ongoing business. But there is a mystery about the buy-in. The dividend was not annnounced prior to payment on 5 April, but the accompanying paperwork said it was being paid on the full c108m shares. That was the number in issue *before* the buy-in. According to Companies House the buy-in had been completed on 7 March, over four weeks before the dividend was paid without prior announcement - although the formal document notifying purchase of own shares, form SHO3, was signed on 7 March but not filed at Co's House until 18 April, less than a week ago. So clarification is needed: did the selling shareholder benefit covertly (by getting on for £1m) from the dividend which the rest of us rabble were not told about? Or was the number of shares on which the dividend was paid, incorrectly stated in the accompanying announcement, as c108m shares when it should have been c103m? It's hard to know whether to be delighted at the unexpected windfall dividend and the evident boost to liquidity, or p*ssed off at the feeling that PI shareholders are being treated like mushrooms [kept in the dark and fed on sh*t] and that the outgoing shareholder may have gained a secret advantage. |
Posted at 23/4/2024 23:49 by mfhmfh Was anyone else paid a dividend on 19th April? |
Posted at 29/12/2022 11:21 by supernumerary finkie - don't be so lazy!'As previously announced on 23 November 2022, following the approval of the proposed Cancellation by Shareholders at the General Meeting held today, the last day of dealings in the Company's Ordinary Shares on AIM will be 29 December 2022 and the Cancellation will become effective at 7:00 a.m. on 30 December 2022, subject to a Dealing Notice, as defined in the AIM Rules for Companies, being issued. The Re-Registration of the Company as a private company is expected to take place on or around 18 January 2023.' yes yes; but 'at a lower price' makes no sense 9degrees - yes, farewell indeed. Been in and out here in the past, and was contemplating buying a chunk again, but saved by the bell. I suspect, however, they'll be back in some form or other... |
Posted at 29/12/2022 10:09 by 9degrees Good bye SBI I feel i have been ripped off whatever their good intentions |
Posted at 09/12/2022 14:23 by assword Just sold for 110 and moved on. Take the hit and learn a lesson or two. Thought best strike now with what little I got out of SBI to move for a stock awaiting results before end of Q4. At least I had the money to trade with now, rather than later. Hopefully it's a double bagger and I get back what I lost out on !!! |
Posted at 08/12/2022 13:33 by assword No dividend carrot offered to see a share price rise. Poor directorship / communications. Bunch of shysters doing it time and again. I don't know how they sleep at night. |
Posted at 09/11/2022 08:11 by brummy_git Planned 115p/share tender offer for SourceBio shareholders, before going private.All the news here www.linkedin.com/pos |
Posted at 13/9/2022 14:24 by c3479z what disturbs is that the CFO gave a summary at the presentation without mentioning, as far as memory serves, that the group made a loss, reinforcing the cherry-picking approach also adopted at the results announcement where readers had to scan down almost towards the end of the announcement before this was disclosed.Do agree that there is plenty of opportunity in cellular pathology but the idea that a 24 hour turnaround time can be achieved across the board is false- it may be possible for the simplest specimens and biopsies to present digitised images to the pathologist within 24 hours but for more complex cases a period of specimen fixation, dissection, block selection and processing can mean a 4-5 day period between specimen receipt and slides being available, the overall turnaround time varies with the diligence of the pathologist who must fit in reporting with a number of other commitments,if they work in the NHS also- MDT meetings, post mortems, CPD, specimen dissection... plenty of competition for private work even if SBI and LD combined are the biggest provider: digitisation of slides not all that novel- it's happening also in the NHS where amalgamations between labs could eventually lead to a more efficient service/increased competition for SBI, with on-site molecular pathology/NGS also becoming standard. Agree there is a present global shortage of pathologists and increasing demand for cellular path as the population ages, more endoscopies done, skin biopsies and gynae specimens taken and more complex investigations required - seems that cellular path is not a highly popular specialty among medical graduates since pathology was de-emphasised at the medical schools but staffing tends to go in cycles though no present sign of improvement...especi Overall therefore outlook should be good for their cellular path division especially if they can integrate it with their genomics outfit. |
Posted at 08/9/2022 07:14 by brummy_git Excellent H1 numbers, and positive outlook today from SourceBio's core divisions.All the details & commentary here www.linkedin.com/pos |
Posted at 06/8/2022 18:28 by brummy_git SBI discussed here at 39:50www.linkedin.com/pos |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
